These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15592929)

  • 21. A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasion.
    Heckmann D; Laufs S; Maier P; Zucknick M; Giordano FA; Veldwijk MR; Eckstein V; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Onkologie; 2011; 34(10):502-8. PubMed ID: 21985848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer.
    Urosevic J; Blasco MT; Llorente A; Bellmunt A; Berenguer-Llergo A; Guiu M; Cañellas A; Fernandez E; Burkov I; Clapés M; Cartanà M; Figueras-Puig C; Batlle E; Nebreda AR; Gomis RR
    Cancer Res; 2020 Nov; 80(21):4668-4680. PubMed ID: 32816905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of chemokine receptor CXCR4 and its ligand CXCL12 in the process of proliferation and migration of oral squamous cell carcinoma].
    Yin D; Zhang Z; Gao S; Li B
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):8-12. PubMed ID: 23484292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
    Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
    Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.
    Wang L; Wang L; Yang B; Yang Q; Qiao S; Wang Y; Sun Y
    Clin Exp Metastasis; 2009; 26(8):1049-54. PubMed ID: 19859817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
    Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
    Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
    Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
    Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
    BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.
    Wang B; Wang W; Niu W; Liu E; Liu X; Wang J; Peng C; Liu S; Xu L; Wang L; Niu J
    Carcinogenesis; 2014 Feb; 35(2):282-91. PubMed ID: 24085800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
    Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
    Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Shikonin down-regulates CXCR4 expression and inhibits CXCL12-induced migratory responses in colorectal carcinoma cell line SW480].
    Wen ZF; Wei XQ; Guo YW; Zheng FP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):627-9. PubMed ID: 19921580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.
    Dessein AF; Stechly L; Jonckheere N; Dumont P; Monté D; Leteurtre E; Truant S; Pruvot FR; Figeac M; Hebbar M; Lecellier CH; Lesuffleur T; Dessein R; Grard G; Dejonghe MJ; de Launoit Y; Furuichi Y; Prévost G; Porchet N; Gespach C; Huet G
    Cancer Res; 2010 Jun; 70(11):4644-54. PubMed ID: 20460542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
    Kim J; Mori T; Chen SL; Amersi FF; Martinez SR; Kuo C; Turner RR; Ye X; Bilchik AJ; Morton DL; Hoon DS
    Ann Surg; 2006 Jul; 244(1):113-20. PubMed ID: 16794396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.
    Jia Y; Zhang S; Miao L; Wang J; Jin Z; Gu B; Duan Z; Zhao Z; Ma S; Zhang W; Li Z
    Oncol Rep; 2015 Jun; 33(6):2681-8. PubMed ID: 25846512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
    Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
    Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus.
    Wald O; Pappo O; Safadi R; Dagan-Berger M; Beider K; Wald H; Franitza S; Weiss I; Avniel S; Boaz P; Hanna J; Zamir G; Eid A; Mandelboim O; Spengler U; Galun E; Peled A
    Eur J Immunol; 2004 Apr; 34(4):1164-74. PubMed ID: 15048728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.
    Li Z; Li N; Wu M; Li X; Luo Z; Wang X
    Mol Cell Biochem; 2013 Sep; 381(1-2):233-42. PubMed ID: 23744532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.